Literature DB >> 8439931

Aerosol therapy in Canada: what are the standards?

K R Chapman.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8439931      PMCID: PMC1490582     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Low first-spray drug content in albuterol metered-dose inhalers.

Authors:  T D Cyr; S J Graham; K Y Li; E G Lovering
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

2.  Bioequivalence of generic aerosol bronchodilators: what are the issues?

Authors:  M Spino
Journal:  CMAJ       Date:  1989-11-01       Impact factor: 8.262

3.  The assessment and treatment of asthma: a conference report.

Authors:  F E Hargreave; J Dolovich; M T Newhouse
Journal:  J Allergy Clin Immunol       Date:  1990-06       Impact factor: 10.793

Review 4.  Aerosol therapy of reversible airflow obstruction. Concepts and clinical applications.

Authors:  M T Newhouse; M Dolovich
Journal:  Chest       Date:  1987-05       Impact factor: 9.410

Review 5.  Control of asthma by aerosols.

Authors:  M T Newhouse; M B Dolovich
Journal:  N Engl J Med       Date:  1986-10-02       Impact factor: 91.245

6.  Deposition and fate of aerosolized drugs.

Authors:  M T Newhouse; R E Ruffin
Journal:  Chest       Date:  1978-06       Impact factor: 9.410

7.  Optimal delivery of aerosols from metered dose inhalers.

Authors:  M Dolovich; R E Ruffin; R Roberts; M T Newhouse
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

8.  Use of spacers to facilitate inhaled corticosteroid treatment of asthma.

Authors:  J H Toogood; J Baskerville; B Jennings; N M Lefcoe; S A Johansson
Journal:  Am Rev Respir Dis       Date:  1984-05

9.  Evaluation of a generic albuterol metered-dose inhaler: importance of priming the MDI.

Authors:  K V Blake; E Harman; L Hendeles
Journal:  Ann Allergy       Date:  1992-02

10.  Differing bioavailability of salbutamol metered-dose inhalers.

Authors:  S K Chhabra
Journal:  J Asthma       Date:  1987       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.